Background
redensity 2 left top
redensity 2  bottom
product

HYALURONIC ACID + LIDOCAINE INJECTION

TEOSYAL RHA® 4

Designed to provide volume in dynamic extended areas such as the cheeks and facial contours

Do you want to softly bring back the lost volume to your patients' faces, avoiding the dreadful 'chipmunk' effect? 

TEOSYAL RHA® 4 is recommended to create or restore volume in the dynamic extended areas of the face, especially the cheeks and contours. 

Designed to provide volume in dynamic extended areas such as the cheeks and facial contours

  • TEOSYAL RHA® 4
«
You've got an aesthetic improvement without feeling the product in the skin and soft tissue - That's great. »

Is indicated for cheek and upper cheek augmentation and redefining the contours of the face, correcting tear troughs and minor ptosis, and filling deep wrinkles in thick skin on the face.

Dr Wolfgang Redka-Swoboda, Germany


Before & after

Treatment of a 38 years old patient with 1,8 mL of RHA® 4, 2 weeks after treatment

Before

Before

After

After

Courtesy of Dr Wolfgang Redka-Swoboda

ABOUT TEOSYAL RHA® 4

  • Product Benefits
  • Indications
  • Technology
  1. Study 1303: Quantitative and comparative safety and effectiveness analysis of three non-CE approved injectable dermal fillers in moderate and severe nasolabial folds treatment versus CE approved comparators.
    A randomized double-blinded, within-subject clinical trial

    • TEOSYAL RHA® 2 vs Juvederm® Volift with Lidocaine
    • TEOSYAL RHA®3 vs Juvederm® Ultra 4
    • TEOSYAL RHA®4 vs Teosyal®PureSense Ultra Deep


    Study 1402: A controlled, randomized, double-blinded, within-subject, multicenter, prospective clinical study of TEOSYAL® RHA Ultra Deep (RHA®4/ TPUL) versus Perlane-L® in the treatment of moderate to severe nasolabial folds.

  2. TEOSYAL RHA® 4 is indicated for creating or restoring volume in the broader areas of the face, such as the facial contour and the cheeks. It can also be used to treat very deep skin breaks on thick skin.

    Principal characteristics:

    • Crosslinked HA
    • HA concentration: 23 mg/mL
    • Degree of modification: 4.0%
    • Lidocaine: 0.3%
    • Needle: 27G x 1/2"
    • Injection depth: subcutaneous tissue, ideally the superficial fat compartments (hypodermis)
  3. 1st RESILIENT HYALURONIC ACID DEDICATED TO FACIAL DYNAMICS

    Resulting from xx years of process optimization (6 patents families filed)*, our "Preserved Network" technology allows us to use low amounts of BDDE** and prepare gels with: 

    • Long HA chains (High Molecular Weight) and,
    • A low degree of modification***


    *WO2010131175, WO2012077054, WO2012077055, WO2014064633, WO2014064632, WO2016096920
    ** BDDE: 1,4-Butanediol Diglycidyl Ether
    ***TEOXANE Laboratories. Data on file, measurement by an independent laboratory of the HA Degree of Modification by 1H NMR

Find a practitioner

Required fields*

I agree to receive exclusive offers and the latest news from Hyaluronic-acid.com
Choose your country

Close

close
Europe

France

UK

Germany

Italy

Poland

Switzerland

Spain

Russia

International

English

French

Asia Pacific

Australia

Malaysia

Come back to consumer area

You are switching to our professional universe

close